Chaste tree

Last Updated: September 28, 2022

Vitex agnus-castus, also called Chaste Tree, is a flowering plant often used to alleviate premenstrual syndrome.

Chaste tree is most often used for

Summary

Vitex agnus-castus is a supplement derived from berries. It is also called Vitex, Chaste Tree, or Chasteberry.

It is primarily used today to alleviate the symptoms of premenstrual syndrome. Vitex agnus-castus has outperformed placebo in numerous trials, and has been shown to be effective at reducing hot flashes, bloating, irritability, sleep disturbances, depressions, various mood disorders and even cramping associated with premenstrual syndrome.

Though animal evidence suggests that taking Vitex agnus-castus may increase estrogen and progesterone levels, further research is needed to confirm this effect. Vitex agnus-castus has limited use outside of its effects on premenstrual syndrome.

Vitex agnus-castus acts similarly to dopamine, by reducing prolactin levels, which are elevated during premenstrual syndrome. It may also act on the opioid system by releasing beta-endorphins, something the human body lacks during premenstrual syndrome.

Though Vitex agnus-castus has been used for a long time, by people that also use birth control, further research is needed to confirm its safety. It does not appear to interact with any pharmaceuticals, but because of the lack of evidence, pregnant or lactating women should not take Vitex agnus-castus.

What else is Chaste tree known as?
Note that Chaste tree is also known as:
  • Chaste Tree
  • VAC
  • Chasteberry
  • Vitex Agnus-castus
Dosage information

Vitex agnus-castus supplements are based on the dry weight of the plant’s fruit. The standard dose is between 150-250mg. There are also two extractions of Vitex agnus-castus:

BNO 1095 is a 10:1 extraction and provides benefits at doses as low as 4 mg.

Ze 110 is a 6-12:1 extraction and provides benefits at doses of 20mg.

Examine Database: Chaste tree
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research